Horse TAFI (Thrombin Acivatable Fibrinolysis Inhibitor) ELISA Kit (HRFI0034)

Assay Genie's equine TAFI ELISA kit enables quantitative measurement of Thrombin Activatable Fibrinolysis Inhibitor in samples from horses. TAFI, also known as carboxypeptidase B2 (CPB2), is a plasma zymogen linking coagulation and fibrinolysis; once activated by the thrombin-thrombomodulin complex, it removes C-terminal lysine residues from fibrin and slows clot dissolution. In equine medicine, circulating TAFI concentrations have been studied in gastrointestinal disorders that disturb hemostasis, in exercise-related shifts of the clotting cascade, and in inflammatory states that rebalance fibrinolysis. The assay is calibrated for horse-specific reactivity, supporting veterinary research, comparative coagulation studies, and translational work on fibrinolytic pathways in sport, racing, and breeding horses.

Researchers apply this kit to breed-related comparisons of hemostatic profiles and to disease models in which attenuated fibrinolysis is suspected, such as colitis, laminitis-associated microthrombosis, and post-operative coagulopathies. The plate-based workflow is read on a standard microplate reader, and the kit should be kept refrigerated between uses to maintain reagent activity. All reagents are supplied in a single pack configured for routine laboratory schedules, including the buffers and standards needed for an in vitro quantitative readout.